Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Imetelstat |
| Trade Name | Rytelo |
| Synonyms | GRN163L|JNJ-63935937|GRN 163L |
| Drug Descriptions |
Rytelo (imetelstat) inhibits telomerase activity, resulting in telomere shortening and potentially leading to increased tumor cell death (PMID: 20048334, PMID: 32571117). Rytelo (imetelstat) is FDA-approved for use in patients with myelodysplastic syndromes with transfusion-dependent anemia (FDA.gov). |
| DrugClasses | |
| CAS Registry Number | 868169-64-6 |
| NCIT ID | C49084 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cytarabine + Fludarabine + Imetelstat | Cytarabine Fludarabine Imetelstat | 0 | 1 |
| Imetelstat | Imetelstat | 0 | 3 |
| Imetelstat + Radiotherapy | Imetelstat Radiotherapy | 0 | 0 |